サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1089567

世界の非感染性前部ぶどう膜炎治療薬市場：考察と予測 (2028年まで)

Global Non-infectious Anterior Uveitis Treatment Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 89 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界の非感染性前部ぶどう膜炎治療薬市場：考察と予測 (2028年まで)
出版日: 2022年06月16日
発行: QYResearch
ページ情報: 英文 89 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、非感染性前部ぶどう膜炎治療薬 (Non-infectious Anterior Uveitis Treatment) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 非感染性前部ぶどう膜炎治療薬の製品概要
  • 市場：タイプ別
    • 世界の非感染性前部ぶどう膜炎治療薬の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Corticosteroid Drug
    • Immunosuppressant Drug
    • Others
  • 市場：アプリケーション別
    • 世界の非感染性前部ぶどう膜炎治療薬の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Hospitals
    • Eye Clinics
    • Home Treatment
    • Others
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の非感染性前部ぶどう膜炎治療薬の販売 推定および予測 2017-2028
  • 世界の非感染性前部ぶどう膜炎治療薬の収益 推定および予測 2017-2028
  • 世界の非感染性前部ぶどう膜炎治療薬の収益：地域別: 2017 VS 2021 VS 2028
  • 世界の非感染性前部ぶどう膜炎治療薬の販売：地域別
    • 世界の非感染性前部ぶどう膜炎治療薬の販売：地域別 (2017-2022)
    • 世界の販売 非感染性前部ぶどう膜炎治療薬 ：地域別 (2023-2028)
  • 世界の非感染性前部ぶどう膜炎治療薬の収益：地域別
    • 世界の非感染性前部ぶどう膜炎治療薬の収益：地域別 (2017-2022)
    • 世界の非感染性前部ぶどう膜炎治療薬の収益：地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第3章 競合：メーカー別

  • 世界の非感染性前部ぶどう膜炎治療薬の販売：メーカー別
    • 世界の非感染性前部ぶどう膜炎治療薬の上位メーカー：販売別 (2017-2022)
    • 世界の非感染性前部ぶどう膜炎治療薬の販売市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー： 非感染性前部ぶどう膜炎治療薬2021
  • 世界の非感染性前部ぶどう膜炎治療薬の収益：メーカー別
    • 世界の非感染性前部ぶどう膜炎治療薬の収益：メーカー別 (2017-2022)
    • 世界の非感染性前部ぶどう膜炎治療薬の収益市場シェア：メーカー別 (2017-2022)
    • 世界の上位10・上位5企業： 非感染性前部ぶどう膜炎治療薬の収益 2021
  • 世界の非感染性前部ぶどう膜炎治療薬の販売価格：メーカー別 (2017-2022)
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界の非感染性前部ぶどう膜炎治療薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界の非感染性前部ぶどう膜炎治療薬のメーカーの地理的分布
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の非感染性前部ぶどう膜炎治療薬の販売：タイプ別
    • 世界の非感染性前部ぶどう膜炎治療薬の販売実績：タイプ別 (2017-2022)
    • 世界の非感染性前部ぶどう膜炎治療薬の販売予測：タイプ別 (2023-2028)
    • 世界の非感染性前部ぶどう膜炎治療薬の販売市場シェア：タイプ別 (2017-2028)
  • 世界の非感染性前部ぶどう膜炎治療薬の収益：タイプ別
    • 世界の非感染性前部ぶどう膜炎治療薬の収益実績：タイプ別 (2017-2022)
    • 世界の非感染性前部ぶどう膜炎治療薬の収益予測：タイプ別 (2023-2028)
    • 世界の非感染性前部ぶどう膜炎治療薬の収益市場シェア：タイプ別 (2017-2028)
  • 世界の非感染性前部ぶどう膜炎治療薬の価格：タイプ別
    • 世界の非感染性前部ぶどう膜炎治療薬の価格：タイプ別 (2017-2022)
    • 世界の非感染性前部ぶどう膜炎治療薬の価格予測：タイプ別 (2023-2028)

第5章 市場規模：アプリケーション別

  • 世界の非感染性前部ぶどう膜炎治療薬の販売：アプリケーション別
    • 世界の非感染性前部ぶどう膜炎治療薬の販売実績：アプリケーション別 (2017-2022)
    • 世界の非感染性前部ぶどう膜炎治療薬の販売予測：アプリケーション別 (2023-2028)
    • 世界の非感染性前部ぶどう膜炎治療薬の販売市場シェア：アプリケーション別 (2017-2028)
  • 世界の非感染性前部ぶどう膜炎治療薬の収益：アプリケーション別
    • 世界の非感染性前部ぶどう膜炎治療薬の収益実績：アプリケーション別 (2017-2022)
    • 世界の非感染性前部ぶどう膜炎治療薬の収益予測：アプリケーション別 (2023-2028)
    • 世界の非感染性前部ぶどう膜炎治療薬の収益市場シェア：アプリケーション別 (2017-2028)
  • 世界の非感染性前部ぶどう膜炎治療薬の価格：アプリケーション別
    • 世界の非感染性前部ぶどう膜炎治療薬の価格：アプリケーション別 (2017-2022)
    • 世界の非感染性前部ぶどう膜炎治療薬の価格予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の非感染性前部ぶどう膜炎治療薬 市場規模：タイプ別
    • 北米の非感染性前部ぶどう膜炎治療薬の販売：タイプ別 (2017-2028)
    • 北米の非感染性前部ぶどう膜炎治療薬の収益：タイプ別 (2017-2028)
  • 北米の非感染性前部ぶどう膜炎治療薬 市場規模：アプリケーション別
    • 北米の非感染性前部ぶどう膜炎治療薬の販売：アプリケーション別 (2017-2028)
    • 北米の非感染性前部ぶどう膜炎治療薬の収益：アプリケーション別 (2017-2028)
  • 北米の非感染性前部ぶどう膜炎治療薬 市場規模：国別
    • 北米の非感染性前部ぶどう膜炎治療薬の販売：国別 (2017-2028)
    • 北米の非感染性前部ぶどう膜炎治療薬の収益：国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の非感染性前部ぶどう膜炎治療薬 市場規模：タイプ別
    • 欧州の非感染性前部ぶどう膜炎治療薬の販売：タイプ別 (2017-2028)
    • 欧州の非感染性前部ぶどう膜炎治療薬の収益：タイプ別 (2017-2028)
  • 欧州の非感染性前部ぶどう膜炎治療薬 市場規模：アプリケーション別
    • 欧州の非感染性前部ぶどう膜炎治療薬の販売：アプリケーション別 (2017-2028)
    • 欧州の非感染性前部ぶどう膜炎治療薬の収益：アプリケーション別 (2017-2028)
  • 欧州の非感染性前部ぶどう膜炎治療薬 市場規模：国別
    • 欧州の非感染性前部ぶどう膜炎治療薬の販売：国別 (2017-2028)
    • 欧州の非感染性前部ぶどう膜炎治療薬の収益：国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋の非感染性前部ぶどう膜炎治療薬 市場規模：タイプ別
    • アジア太平洋の非感染性前部ぶどう膜炎治療薬の販売：タイプ別 (2017-2028)
    • アジア太平洋の非感染性前部ぶどう膜炎治療薬の収益：タイプ別 (2017-2028)
  • アジア太平洋の非感染性前部ぶどう膜炎治療薬 市場規模：アプリケーション別
    • アジア太平洋の非感染性前部ぶどう膜炎治療薬の販売：アプリケーション別 (2017-2028)
    • アジア太平洋の非感染性前部ぶどう膜炎治療薬の収益：アプリケーション別 (2017-2028)
  • アジア太平洋の非感染性前部ぶどう膜炎治療薬 市場規模：地域別
    • アジア太平洋の非感染性前部ぶどう膜炎治療薬の販売：地域別 (2017-2028)
    • アジア太平洋の非感染性前部ぶどう膜炎治療薬の収益：地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア

第9章 ラテンアメリカ

  • ラテンアメリカの非感染性前部ぶどう膜炎治療薬 市場規模：タイプ別
    • ラテンアメリカの非感染性前部ぶどう膜炎治療薬の販売：タイプ別 (2017-2028)
    • ラテンアメリカの非感染性前部ぶどう膜炎治療薬の収益：タイプ別 (2017-2028)
  • ラテンアメリカの非感染性前部ぶどう膜炎治療薬 市場規模：アプリケーション別
    • ラテンアメリカの非感染性前部ぶどう膜炎治療薬の販売：アプリケーション別 (2017-2028)
    • ラテンアメリカの非感染性前部ぶどう膜炎治療薬の収益：アプリケーション別 (2017-2028)
  • ラテンアメリカの非感染性前部ぶどう膜炎治療薬 市場規模：国別
    • ラテンアメリカの非感染性前部ぶどう膜炎治療薬の販売：国別 (2017-2028)
    • ラテンアメリカの非感染性前部ぶどう膜炎治療薬の収益：国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカ

  • 中東・アフリカの非感染性前部ぶどう膜炎治療薬 市場規模：タイプ別
    • 中東・アフリカの非感染性前部ぶどう膜炎治療薬の販売：タイプ別 (2017-2028)
    • 中東・アフリカの非感染性前部ぶどう膜炎治療薬の収益：タイプ別 (2017-2028)
  • 中東・アフリカの非感染性前部ぶどう膜炎治療薬 市場規模：アプリケーション別
    • 中東・アフリカの非感染性前部ぶどう膜炎治療薬の販売：アプリケーション別 (2017-2028)
    • 中東・アフリカの非感染性前部ぶどう膜炎治療薬の収益：アプリケーション別 (2017-2028)
  • 中東・アフリカの非感染性前部ぶどう膜炎治療薬 市場規模：国別
    • 中東・アフリカの非感染性前部ぶどう膜炎治療薬の販売：国別 (2017-2028)
    • 中東・アフリカの非感染性前部ぶどう膜炎治療薬の収益：国別 (2017-2028)
    • トルコ
    • サウジアラビア

第11章 企業プロファイル

  • Bausch & Lomb
  • Santen Pharmaceutical
  • AbbVie
  • OKYO
  • Novartis
  • Eyegate Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Eyepoint pharmaceuticals
  • Alimera Sciences

第12章 業界チェーンと販売チャネルの分析

  • 非感染性前部ぶどう膜炎治療薬 業界チェーン分析
  • 非感染性前部ぶどう膜炎治療薬 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • 非感染性前部ぶどう膜炎治療薬 生産形態とプロセス
  • 非感染性前部ぶどう膜炎治療薬 販売およびマーケティング
    • 非感染性前部ぶどう膜炎治療薬 販売チャネル
    • 非感染性前部ぶどう膜炎治療薬 卸業者
  • 非感染性前部ぶどう膜炎治療薬 顧客

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

  • 非感染性前部ぶどう膜炎治療薬 業界動向
  • 非感染性前部ぶどう膜炎治療薬 市場の促進要因
  • 非感染性前部ぶどう膜炎治療薬 市場の課題
  • 非感染性前部ぶどう膜炎治療薬 市場の抑制要因

第14章 世界の非感染性前部ぶどう膜炎治療薬の主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Non-infectious Anterior Uveitis Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Corticosteroid Drug
  • Table 3. Major Manufacturers of Immunosuppressant Drug
  • Table 4. Major Manufacturers of Others
  • Table 5. Global Non-infectious Anterior Uveitis Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global Non-infectious Anterior Uveitis Treatment Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 7. Global Non-infectious Anterior Uveitis Treatment Sales by Region (2017-2022) & (K Units)
  • Table 8. Global Non-infectious Anterior Uveitis Treatment Sales Market Share by Region (2017-2022)
  • Table 9. Global Non-infectious Anterior Uveitis Treatment Sales by Region (2023-2028) & (K Units)
  • Table 10. Global Non-infectious Anterior Uveitis Treatment Sales Market Share by Region (2023-2028)
  • Table 11. Global Non-infectious Anterior Uveitis Treatment Revenue by Region (2017-2022) & (US$ Million)
  • Table 12. Global Non-infectious Anterior Uveitis Treatment Revenue Market Share by Region (2017-2022)
  • Table 13. Global Non-infectious Anterior Uveitis Treatment Revenue by Region (2023-2028) & (US$ Million)
  • Table 14. Global Non-infectious Anterior Uveitis Treatment Revenue Market Share by Region (2023-2028)
  • Table 15. Global Non-infectious Anterior Uveitis Treatment Sales by Manufacturers (2017-2022) & (K Units)
  • Table 16. Global Non-infectious Anterior Uveitis Treatment Sales Share by Manufacturers (2017-2022)
  • Table 17. Global Non-infectious Anterior Uveitis Treatment Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 18. Global Non-infectious Anterior Uveitis Treatment Revenue Share by Manufacturers (2017-2022)
  • Table 19. Non-infectious Anterior Uveitis Treatment Price by Manufacturers (2017-2022) &(US$/Unit)
  • Table 20. Global Non-infectious Anterior Uveitis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 21. Global Non-infectious Anterior Uveitis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-infectious Anterior Uveitis Treatment as of 2021)
  • Table 22. Non-infectious Anterior Uveitis Treatment Manufacturing Base Distribution and Headquarters
  • Table 23. Manufacturers Non-infectious Anterior Uveitis Treatment Product Offered
  • Table 24. Date of Manufacturers Enter into Non-infectious Anterior Uveitis Treatment Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2022) & (K Units)
  • Table 27. Global Non-infectious Anterior Uveitis Treatment Sales by Type (2023-2028) & (K Units)
  • Table 28. Global Non-infectious Anterior Uveitis Treatment Sales Share by Type (2017-2022)
  • Table 29. Global Non-infectious Anterior Uveitis Treatment Sales Share by Type (2023-2028)
  • Table 30. Global Non-infectious Anterior Uveitis Treatment Revenue by Type (2017-2022) & (US$ Million)
  • Table 31. Global Non-infectious Anterior Uveitis Treatment Revenue by Type (2023-2028) & (US$ Million)
  • Table 32. Global Non-infectious Anterior Uveitis Treatment Revenue Share by Type (2017-2022)
  • Table 33. Global Non-infectious Anterior Uveitis Treatment Revenue Share by Type (2023-2028)
  • Table 34. Non-infectious Anterior Uveitis Treatment Price by Type (2017-2022) & (US$/Unit)
  • Table 35. Global Non-infectious Anterior Uveitis Treatment Price Forecast by Type (2023-2028) & (US$/Unit)
  • Table 36. Global Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2022) & (K Units)
  • Table 37. Global Non-infectious Anterior Uveitis Treatment Sales by Application (2023-2028) & (K Units)
  • Table 38. Global Non-infectious Anterior Uveitis Treatment Sales Share by Application (2017-2022)
  • Table 39. Global Non-infectious Anterior Uveitis Treatment Sales Share by Application (2023-2028)
  • Table 40. Global Non-infectious Anterior Uveitis Treatment Revenue by Application (2017-2022) & (US$ Million)
  • Table 41. Global Non-infectious Anterior Uveitis Treatment Revenue by Application (2023-2028) & (US$ Million)
  • Table 42. Global Non-infectious Anterior Uveitis Treatment Revenue Share by Application (2017-2022)
  • Table 43. Global Non-infectious Anterior Uveitis Treatment Revenue Share by Application (2023-2028)
  • Table 44. Non-infectious Anterior Uveitis Treatment Price by Application (2017-2022) & (US$/Unit)
  • Table 45. Global Non-infectious Anterior Uveitis Treatment Price Forecast by Application (2023-2028) & (US$/Unit)
  • Table 46. North America Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2022) & (K Units)
  • Table 47. North America Non-infectious Anterior Uveitis Treatment Sales by Type (2023-2028) & (K Units)
  • Table 48. North America Non-infectious Anterior Uveitis Treatment Revenue by Type (2017-2022) & (US$ Million)
  • Table 49. North America Non-infectious Anterior Uveitis Treatment Revenue by Type (2023-2028) & (US$ Million)
  • Table 50. North America Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2022) & (K Units)
  • Table 51. North America Non-infectious Anterior Uveitis Treatment Sales by Application (2023-2028) & (K Units)
  • Table 52. North America Non-infectious Anterior Uveitis Treatment Revenue by Application (2017-2022) & (US$ Million)
  • Table 53. North America Non-infectious Anterior Uveitis Treatment Revenue by Application (2023-2028) & (US$ Million)
  • Table 54. North America Non-infectious Anterior Uveitis Treatment Sales by Country (2017-2022) & (K Units)
  • Table 55. North America Non-infectious Anterior Uveitis Treatment Sales by Country (2023-2028) & (K Units)
  • Table 56. North America Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2022) & (US$ Million)
  • Table 57. North America Non-infectious Anterior Uveitis Treatment Revenue by Country (2023-2028) & (US$ Million)
  • Table 58. Europe Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2022) & (K Units)
  • Table 59. Europe Non-infectious Anterior Uveitis Treatment Sales by Type (2023-2028) & (K Units)
  • Table 60. Europe Non-infectious Anterior Uveitis Treatment Revenue by Type (2017-2022) & (US$ Million)
  • Table 61. Europe Non-infectious Anterior Uveitis Treatment Revenue by Type (2023-2028) & (US$ Million)
  • Table 62. Europe Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2022) & (K Units)
  • Table 63. Europe Non-infectious Anterior Uveitis Treatment Sales by Application (2023-2028) & (K Units)
  • Table 64. Europe Non-infectious Anterior Uveitis Treatment Revenue by Application (2017-2022) & (US$ Million)
  • Table 65. Europe Non-infectious Anterior Uveitis Treatment Revenue by Application (2023-2028) & (US$ Million)
  • Table 66. Europe Non-infectious Anterior Uveitis Treatment Sales by Country (2017-2022) & (K Units)
  • Table 67. Europe Non-infectious Anterior Uveitis Treatment Sales by Country (2023-2028) & (K Units)
  • Table 68. Europe Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2022) & (US$ Million)
  • Table 69. Europe Non-infectious Anterior Uveitis Treatment Revenue by Country (2023-2028) & (US$ Million)
  • Table 70. Asia Pacific Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2022) & (K Units)
  • Table 71. Asia Pacific Non-infectious Anterior Uveitis Treatment Sales by Type (2023-2028) & (K Units)
  • Table 72. Asia Pacific Non-infectious Anterior Uveitis Treatment Revenue by Type (2017-2022) & (US$ Million)
  • Table 73. Asia Pacific Non-infectious Anterior Uveitis Treatment Revenue by Type (2023-2028) & (US$ Million)
  • Table 74. Asia Pacific Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2022) & (K Units)
  • Table 75. Asia Pacific Non-infectious Anterior Uveitis Treatment Sales by Application (2023-2028) & (K Units)
  • Table 76. Asia Pacific Non-infectious Anterior Uveitis Treatment Revenue by Application (2017-2022) & (US$ Million)
  • Table 77. Asia Pacific Non-infectious Anterior Uveitis Treatment Revenue by Application (2023-2028) & (US$ Million)
  • Table 78. Asia Pacific Non-infectious Anterior Uveitis Treatment Sales by Region (2017-2022) & (K Units)
  • Table 79. Asia Pacific Non-infectious Anterior Uveitis Treatment Sales by Region (2023-2028) & (K Units)
  • Table 80. Asia Pacific Non-infectious Anterior Uveitis Treatment Revenue by Region (2017-2022) & (US$ Million)
  • Table 81. Asia Pacific Non-infectious Anterior Uveitis Treatment Revenue by Region (2023-2028) & (US$ Million)
  • Table 82. Latin America Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2022) & (K Units)
  • Table 83. Latin America Non-infectious Anterior Uveitis Treatment Sales by Type (2023-2028) & (K Units)
  • Table 84. Latin America Non-infectious Anterior Uveitis Treatment Revenue by Type (2017-2022) & (US$ Million)
  • Table 85. Latin America Non-infectious Anterior Uveitis Treatment Revenue by Type (2023-2028) & (US$ Million)
  • Table 86. Latin America Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2022) & (K Units)
  • Table 87. Latin America Non-infectious Anterior Uveitis Treatment Sales by Application (2023-2028) & (K Units)
  • Table 88. Latin America Non-infectious Anterior Uveitis Treatment Revenue by Application (2017-2022) & (US$ Million)
  • Table 89. Latin America Non-infectious Anterior Uveitis Treatment Revenue by Application (2023-2028) & (US$ Million)
  • Table 90. Latin America Non-infectious Anterior Uveitis Treatment Sales by Country (2017-2022) & (K Units)
  • Table 91. Latin America Non-infectious Anterior Uveitis Treatment Sales by Country (2023-2028) & (K Units)
  • Table 92. Latin America Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2022) & (US$ Million)
  • Table 93. Latin America Non-infectious Anterior Uveitis Treatment Revenue by Country (2023-2028) & (US$ Million)
  • Table 94. Middle East and Africa Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2022) & (K Units)
  • Table 95. Middle East and Africa Non-infectious Anterior Uveitis Treatment Sales by Type (2023-2028) & (K Units)
  • Table 96. Middle East and Africa Non-infectious Anterior Uveitis Treatment Revenue by Type (2017-2022) & (US$ Million)
  • Table 97. Middle East and Africa Non-infectious Anterior Uveitis Treatment Revenue by Type (2023-2028) & (US$ Million)
  • Table 98. Middle East and Africa Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2022) & (K Units)
  • Table 99. Middle East and Africa Non-infectious Anterior Uveitis Treatment Sales by Application (2023-2028) & (K Units)
  • Table 100. Middle East and Africa Non-infectious Anterior Uveitis Treatment Revenue by Application (2017-2022) & (US$ Million)
  • Table 101. Middle East and Africa Non-infectious Anterior Uveitis Treatment Revenue by Application (2023-2028) & (US$ Million)
  • Table 102. Middle East and Africa Non-infectious Anterior Uveitis Treatment Sales by Country (2017-2022) & (K Units)
  • Table 103. Middle East and Africa Non-infectious Anterior Uveitis Treatment Sales by Country (2023-2028) & (K Units)
  • Table 104. Middle East and Africa Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2022) & (US$ Million)
  • Table 105. Middle East and Africa Non-infectious Anterior Uveitis Treatment Revenue by Country (2023-2028) & (US$ Million)
  • Table 106. Bausch & Lomb Corporation Information
  • Table 107. Bausch & Lomb Description and Major Businesses
  • Table 108. Bausch & Lomb Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 109. Bausch & Lomb Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 110. Bausch & Lomb Recent Developments
  • Table 111. Santen Pharmaceutical Corporation Information
  • Table 112. Santen Pharmaceutical Description and Major Businesses
  • Table 113. Santen Pharmaceutical Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 114. Santen Pharmaceutical Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 115. Santen Pharmaceutical Recent Developments
  • Table 116. AbbVie Corporation Information
  • Table 117. AbbVie Description and Major Businesses
  • Table 118. AbbVie Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 119. AbbVie Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 120. AbbVie Recent Developments
  • Table 121. OKYO Corporation Information
  • Table 122. OKYO Description and Major Businesses
  • Table 123. OKYO Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 124. OKYO Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 125. OKYO Recent Developments
  • Table 126. Novartis Corporation Information
  • Table 127. Novartis Description and Major Businesses
  • Table 128. Novartis Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 129. Novartis Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 130. Novartis Recent Developments
  • Table 131. Eyegate Pharmaceuticals Corporation Information
  • Table 132. Eyegate Pharmaceuticals Description and Major Businesses
  • Table 133. Eyegate Pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 134. Eyegate Pharmaceuticals Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 135. Eyegate Pharmaceuticals Recent Developments
  • Table 136. Regeneron Pharmaceuticals Corporation Information
  • Table 137. Regeneron Pharmaceuticals Description and Major Businesses
  • Table 138. Regeneron Pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 139. Regeneron Pharmaceuticals Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 140. Regeneron Pharmaceuticals Recent Developments
  • Table 141. Eyepoint pharmaceuticals Corporation Information
  • Table 142. Eyepoint pharmaceuticals Description and Major Businesses
  • Table 143. Eyepoint pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 144. Eyepoint pharmaceuticals Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 145. Eyepoint pharmaceuticals Recent Developments
  • Table 146. Alimera Sciences Corporation Information
  • Table 147. Alimera Sciences Description and Major Businesses
  • Table 148. Alimera Sciences Non-infectious Anterior Uveitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 149. Alimera Sciences Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 150. Alimera Sciences Recent Developments
  • Table 151. Key Raw Materials Lists
  • Table 152. Raw Materials Key Suppliers Lists
  • Table 153. Non-infectious Anterior Uveitis Treatment Distributors List
  • Table 154. Non-infectious Anterior Uveitis Treatment Customers List
  • Table 155. Non-infectious Anterior Uveitis Treatment Market Trends
  • Table 156. Non-infectious Anterior Uveitis Treatment Market Drivers
  • Table 157. Non-infectious Anterior Uveitis Treatment Market Challenges
  • Table 158. Non-infectious Anterior Uveitis Treatment Market Restraints
  • Table 159. Research Programs/Design for This Report
  • Table 160. Key Data Information from Secondary Sources
  • Table 161. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Non-infectious Anterior Uveitis Treatment Product Picture
  • Figure 3. Global Non-infectious Anterior Uveitis Treatment Market Share by Type in 2021 & 2028
  • Figure 3. Corticosteroid Drug Product Picture
  • Figure 4. Immunosuppressant Drug Product Picture
  • Figure 5. Others Product Picture
  • Figure 6. Global Non-infectious Anterior Uveitis Treatment Market Share by Application in 2021 & 2028
  • Figure 7. Hospitals
  • Figure 8. Eye Clinics
  • Figure 9. Home Treatment
  • Figure 10. Others
  • Figure 11. Non-infectious Anterior Uveitis Treatment Report Years Considered
  • Figure 12. Global Non-infectious Anterior Uveitis Treatment Sales 2017-2028 (K Units)
  • Figure 13. Global Non-infectious Anterior Uveitis Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 14. Global Non-infectious Anterior Uveitis Treatment Revenue 2017-2028 (US$ Million)
  • Figure 15. Global Non-infectious Anterior Uveitis Treatment Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 16. Global Non-infectious Anterior Uveitis Treatment Sales Market Share by Region (2017-2022)
  • Figure 17. Global Non-infectious Anterior Uveitis Treatment Sales Market Share by Region (2023-2028)
  • Figure 18. North America Non-infectious Anterior Uveitis Treatment Sales YoY (2017-2028) & (K Units)
  • Figure 19. North America Non-infectious Anterior Uveitis Treatment Revenue YoY (2017-2028) & (US$ Million)
  • Figure 20. Europe Non-infectious Anterior Uveitis Treatment Sales YoY (2017-2028) & (K Units)
  • Figure 21. Europe Non-infectious Anterior Uveitis Treatment Revenue YoY (2017-2028) & (US$ Million)
  • Figure 22. Asia-Pacific Non-infectious Anterior Uveitis Treatment Sales YoY (2017-2028) & (K Units)
  • Figure 23. Asia-Pacific Non-infectious Anterior Uveitis Treatment Revenue YoY (2017-2028) & (US$ Million)
  • Figure 24. Latin America Non-infectious Anterior Uveitis Treatment Sales YoY (2017-2028) & (K Units)
  • Figure 25. Latin America Non-infectious Anterior Uveitis Treatment Revenue YoY (2017-2028) & (US$ Million)
  • Figure 26. Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales YoY (2017-2028) & (K Units)
  • Figure 27. Middle East & Africa Non-infectious Anterior Uveitis Treatment Revenue YoY (2017-2028) & (US$ Million)
  • Figure 28. The Non-infectious Anterior Uveitis Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 29. The Top 5 and 10 Largest Manufacturers of Non-infectious Anterior Uveitis Treatment in the World: Market Share by Non-infectious Anterior Uveitis Treatment Revenue in 2021
  • Figure 30. Global Non-infectious Anterior Uveitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 31. Global Non-infectious Anterior Uveitis Treatment Sales Market Share by Type (2017-2028)
  • Figure 32. Global Non-infectious Anterior Uveitis Treatment Revenue Market Share by Type (2017-2028)
  • Figure 33. Global Non-infectious Anterior Uveitis Treatment Sales Market Share by Application (2017-2028)
  • Figure 34. Global Non-infectious Anterior Uveitis Treatment Revenue Market Share by Application (2017-2028)
  • Figure 35. North America Non-infectious Anterior Uveitis Treatment Sales Market Share by Type (2017-2028)
  • Figure 36. North America Non-infectious Anterior Uveitis Treatment Revenue Market Share by Type (2017-2028)
  • Figure 37. North America Non-infectious Anterior Uveitis Treatment Sales Market Share by Application (2017-2028)
  • Figure 38. North America Non-infectious Anterior Uveitis Treatment Revenue Market Share by Application (2017-2028)
  • Figure 39. North America Non-infectious Anterior Uveitis Treatment Sales Share by Country (2017-2028)
  • Figure 40. North America Non-infectious Anterior Uveitis Treatment Revenue Share by Country (2017-2028)
  • Figure 41. United States Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 42. Canada Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 43. Europe Non-infectious Anterior Uveitis Treatment Sales Market Share by Type (2017-2028)
  • Figure 44. Europe Non-infectious Anterior Uveitis Treatment Revenue Market Share by Type (2017-2028)
  • Figure 45. Europe Non-infectious Anterior Uveitis Treatment Sales Market Share by Application (2017-2028)
  • Figure 46. Europe Non-infectious Anterior Uveitis Treatment Revenue Market Share by Application (2017-2028)
  • Figure 47. Europe Non-infectious Anterior Uveitis Treatment Sales Share by Country (2017-2028)
  • Figure 48. Europe Non-infectious Anterior Uveitis Treatment Revenue Share by Country (2017-2028)
  • Figure 49. Germany Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 50. France Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 51. U.K. Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 52. Italy Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 53. Russia Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 54. Asia Pacific Non-infectious Anterior Uveitis Treatment Sales Market Share by Type (2017-2028)
  • Figure 55. Asia Pacific Non-infectious Anterior Uveitis Treatment Revenue Market Share by Type (2017-2028)
  • Figure 56. Asia Pacific Non-infectious Anterior Uveitis Treatment Sales Market Share by Application (2017-2028)
  • Figure 57. Asia Pacific Non-infectious Anterior Uveitis Treatment Revenue Market Share by Application (2017-2028)
  • Figure 58. Asia Pacific Non-infectious Anterior Uveitis Treatment Sales Share by Region (2017-2028)
  • Figure 59. Asia Pacific Non-infectious Anterior Uveitis Treatment Revenue Share by Region (2017-2028)
  • Figure 60. China Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 61. Japan Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 62. South Korea Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 63. India Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 64. Australia Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 65. China Taiwan Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 66. Indonesia Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 67. Thailand Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 68. Malaysia Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 69. Latin America Non-infectious Anterior Uveitis Treatment Sales Market Share by Type (2017-2028)
  • Figure 70. Latin America Non-infectious Anterior Uveitis Treatment Revenue Market Share by Type (2017-2028)
  • Figure 71. Latin America Non-infectious Anterior Uveitis Treatment Sales Market Share by Application (2017-2028)
  • Figure 72. Latin America Non-infectious Anterior Uveitis Treatment Revenue Market Share by Application (2017-2028)
  • Figure 73. Latin America Non-infectious Anterior Uveitis Treatment Sales Share by Country (2017-2028)
  • Figure 74. Latin America Non-infectious Anterior Uveitis Treatment Revenue Share by Country (2017-2028)
  • Figure 75. Mexico Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 76. Brazil Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 77. Argentina Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 78. Colombia Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 79. Middle East and Africa Non-infectious Anterior Uveitis Treatment Sales Market Share by Type (2017-2028)
  • Figure 80. Middle East and Africa Non-infectious Anterior Uveitis Treatment Revenue Market Share by Type (2017-2028)
  • Figure 81. Middle East and Africa Non-infectious Anterior Uveitis Treatment Sales Market Share by Application (2017-2028)
  • Figure 82. Middle East and Africa Non-infectious Anterior Uveitis Treatment Revenue Market Share by Application (2017-2028)
  • Figure 83. Middle East and Africa Non-infectious Anterior Uveitis Treatment Sales Share by Country (2017-2028)
  • Figure 84. Middle East and Africa Non-infectious Anterior Uveitis Treatment Revenue Share by Country (2017-2028)
  • Figure 85. Turkey Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 86. Saudi Arabia Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 87. UAE Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (US$ Million)
  • Figure 88. Non-infectious Anterior Uveitis Treatment Value Chain
  • Figure 89. Non-infectious Anterior Uveitis Treatment Production Process
  • Figure 90. Channels of Distribution
  • Figure 91. Distributors Profiles
  • Figure 92. Bottom-up and Top-down Approaches for This Report
  • Figure 93. Data Triangulation
  • Figure 94. Key Executives Interviewed
目次

This research report focuses on the Non-infectious Anterior Uveitis Treatment Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Non-infectious Anterior Uveitis Treatment Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Non-infectious Anterior Uveitis Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Corticosteroid Drug
    • 1.2.3 Immunosuppressant Drug
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Non-infectious Anterior Uveitis Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospitals
    • 1.3.3 Eye Clinics
    • 1.3.4 Home Treatment
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Non-infectious Anterior Uveitis Treatment Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Non-infectious Anterior Uveitis Treatment Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Non-infectious Anterior Uveitis Treatment Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Non-infectious Anterior Uveitis Treatment Sales by Region
    • 2.4.1 Global Non-infectious Anterior Uveitis Treatment Sales by Region (2017-2022)
    • 2.4.2 Global Sales Non-infectious Anterior Uveitis Treatment by Region (2023-2028)
  • 2.5 Global Non-infectious Anterior Uveitis Treatment Revenue by Region
    • 2.5.1 Global Non-infectious Anterior Uveitis Treatment Revenue by Region (2017-2022)
    • 2.5.2 Global Non-infectious Anterior Uveitis Treatment Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Non-infectious Anterior Uveitis Treatment Sales by Manufacturers
    • 3.1.1 Global Top Non-infectious Anterior Uveitis Treatment Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Non-infectious Anterior Uveitis Treatment Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Non-infectious Anterior Uveitis Treatment in 2021
  • 3.2 Global Non-infectious Anterior Uveitis Treatment Revenue by Manufacturers
    • 3.2.1 Global Non-infectious Anterior Uveitis Treatment Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Non-infectious Anterior Uveitis Treatment Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Non-infectious Anterior Uveitis Treatment Revenue in 2021
  • 3.3 Global Non-infectious Anterior Uveitis Treatment Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Non-infectious Anterior Uveitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Non-infectious Anterior Uveitis Treatment Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Non-infectious Anterior Uveitis Treatment Sales by Type
    • 4.1.1 Global Non-infectious Anterior Uveitis Treatment Historical Sales by Type (2017-2022)
    • 4.1.2 Global Non-infectious Anterior Uveitis Treatment Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Non-infectious Anterior Uveitis Treatment Sales Market Share by Type (2017-2028)
  • 4.2 Global Non-infectious Anterior Uveitis Treatment Revenue by Type
    • 4.2.1 Global Non-infectious Anterior Uveitis Treatment Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Non-infectious Anterior Uveitis Treatment Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Non-infectious Anterior Uveitis Treatment Revenue Market Share by Type (2017-2028)
  • 4.3 Global Non-infectious Anterior Uveitis Treatment Price by Type
    • 4.3.1 Global Non-infectious Anterior Uveitis Treatment Price by Type (2017-2022)
    • 4.3.2 Global Non-infectious Anterior Uveitis Treatment Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Non-infectious Anterior Uveitis Treatment Sales by Application
    • 5.1.1 Global Non-infectious Anterior Uveitis Treatment Historical Sales by Application (2017-2022)
    • 5.1.2 Global Non-infectious Anterior Uveitis Treatment Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Non-infectious Anterior Uveitis Treatment Sales Market Share by Application (2017-2028)
  • 5.2 Global Non-infectious Anterior Uveitis Treatment Revenue by Application
    • 5.2.1 Global Non-infectious Anterior Uveitis Treatment Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Non-infectious Anterior Uveitis Treatment Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Non-infectious Anterior Uveitis Treatment Revenue Market Share by Application (2017-2028)
  • 5.3 Global Non-infectious Anterior Uveitis Treatment Price by Application
    • 5.3.1 Global Non-infectious Anterior Uveitis Treatment Price by Application (2017-2022)
    • 5.3.2 Global Non-infectious Anterior Uveitis Treatment Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Non-infectious Anterior Uveitis Treatment Market Size by Type
    • 6.1.1 North America Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2028)
    • 6.1.2 North America Non-infectious Anterior Uveitis Treatment Revenue by Type (2017-2028)
  • 6.2 North America Non-infectious Anterior Uveitis Treatment Market Size by Application
    • 6.2.1 North America Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2028)
    • 6.2.2 North America Non-infectious Anterior Uveitis Treatment Revenue by Application (2017-2028)
  • 6.3 North America Non-infectious Anterior Uveitis Treatment Market Size by Country
    • 6.3.1 North America Non-infectious Anterior Uveitis Treatment Sales by Country (2017-2028)
    • 6.3.2 North America Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2028)
    • 6.3.3 United States
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Non-infectious Anterior Uveitis Treatment Market Size by Type
    • 7.1.1 Europe Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2028)
    • 7.1.2 Europe Non-infectious Anterior Uveitis Treatment Revenue by Type (2017-2028)
  • 7.2 Europe Non-infectious Anterior Uveitis Treatment Market Size by Application
    • 7.2.1 Europe Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2028)
    • 7.2.2 Europe Non-infectious Anterior Uveitis Treatment Revenue by Application (2017-2028)
  • 7.3 Europe Non-infectious Anterior Uveitis Treatment Market Size by Country
    • 7.3.1 Europe Non-infectious Anterior Uveitis Treatment Sales by Country (2017-2028)
    • 7.3.2 Europe Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Non-infectious Anterior Uveitis Treatment Market Size by Type
    • 8.1.1 Asia Pacific Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Non-infectious Anterior Uveitis Treatment Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Non-infectious Anterior Uveitis Treatment Market Size by Application
    • 8.2.1 Asia Pacific Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Non-infectious Anterior Uveitis Treatment Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Non-infectious Anterior Uveitis Treatment Market Size by Region
    • 8.3.1 Asia Pacific Non-infectious Anterior Uveitis Treatment Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Non-infectious Anterior Uveitis Treatment Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 China Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia

9 Latin America

  • 9.1 Latin America Non-infectious Anterior Uveitis Treatment Market Size by Type
    • 9.1.1 Latin America Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2028)
    • 9.1.2 Latin America Non-infectious Anterior Uveitis Treatment Revenue by Type (2017-2028)
  • 9.2 Latin America Non-infectious Anterior Uveitis Treatment Market Size by Application
    • 9.2.1 Latin America Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2028)
    • 9.2.2 Latin America Non-infectious Anterior Uveitis Treatment Revenue by Application (2017-2028)
  • 9.3 Latin America Non-infectious Anterior Uveitis Treatment Market Size by Country
    • 9.3.1 Latin America Non-infectious Anterior Uveitis Treatment Sales by Country (2017-2028)
    • 9.3.2 Latin America Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina
    • 9.3.6 Colombia

10 Middle East and Africa

  • 10.1 Middle East and Africa Non-infectious Anterior Uveitis Treatment Market Size by Type
    • 10.1.1 Middle East and Africa Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Non-infectious Anterior Uveitis Treatment Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Non-infectious Anterior Uveitis Treatment Market Size by Application
    • 10.2.1 Middle East and Africa Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Non-infectious Anterior Uveitis Treatment Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Non-infectious Anterior Uveitis Treatment Market Size by Country
    • 10.3.1 Middle East and Africa Non-infectious Anterior Uveitis Treatment Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 Bausch & Lomb
    • 11.1.1 Bausch & Lomb Corporation Information
    • 11.1.2 Bausch & Lomb Overview
    • 11.1.3 Bausch & Lomb Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 Bausch & Lomb Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Bausch & Lomb Recent Developments
  • 11.2 Santen Pharmaceutical
    • 11.2.1 Santen Pharmaceutical Corporation Information
    • 11.2.2 Santen Pharmaceutical Overview
    • 11.2.3 Santen Pharmaceutical Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 Santen Pharmaceutical Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Santen Pharmaceutical Recent Developments
  • 11.3 AbbVie
    • 11.3.1 AbbVie Corporation Information
    • 11.3.2 AbbVie Overview
    • 11.3.3 AbbVie Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 AbbVie Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 AbbVie Recent Developments
  • 11.4 OKYO
    • 11.4.1 OKYO Corporation Information
    • 11.4.2 OKYO Overview
    • 11.4.3 OKYO Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 OKYO Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 OKYO Recent Developments
  • 11.5 Novartis
    • 11.5.1 Novartis Corporation Information
    • 11.5.2 Novartis Overview
    • 11.5.3 Novartis Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 Novartis Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Novartis Recent Developments
  • 11.6 Eyegate Pharmaceuticals
    • 11.6.1 Eyegate Pharmaceuticals Corporation Information
    • 11.6.2 Eyegate Pharmaceuticals Overview
    • 11.6.3 Eyegate Pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 Eyegate Pharmaceuticals Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Eyegate Pharmaceuticals Recent Developments
  • 11.7 Regeneron Pharmaceuticals
    • 11.7.1 Regeneron Pharmaceuticals Corporation Information
    • 11.7.2 Regeneron Pharmaceuticals Overview
    • 11.7.3 Regeneron Pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Regeneron Pharmaceuticals Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Regeneron Pharmaceuticals Recent Developments
  • 11.8 Eyepoint pharmaceuticals
    • 11.8.1 Eyepoint pharmaceuticals Corporation Information
    • 11.8.2 Eyepoint pharmaceuticals Overview
    • 11.8.3 Eyepoint pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 Eyepoint pharmaceuticals Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Eyepoint pharmaceuticals Recent Developments
  • 11.9 Alimera Sciences
    • 11.9.1 Alimera Sciences Corporation Information
    • 11.9.2 Alimera Sciences Overview
    • 11.9.3 Alimera Sciences Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 Alimera Sciences Non-infectious Anterior Uveitis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Alimera Sciences Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Non-infectious Anterior Uveitis Treatment Industry Chain Analysis
  • 12.2 Non-infectious Anterior Uveitis Treatment Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Non-infectious Anterior Uveitis Treatment Production Mode & Process
  • 12.4 Non-infectious Anterior Uveitis Treatment Sales and Marketing
    • 12.4.1 Non-infectious Anterior Uveitis Treatment Sales Channels
    • 12.4.2 Non-infectious Anterior Uveitis Treatment Distributors
  • 12.5 Non-infectious Anterior Uveitis Treatment Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Non-infectious Anterior Uveitis Treatment Industry Trends
  • 13.2 Non-infectious Anterior Uveitis Treatment Market Drivers
  • 13.3 Non-infectious Anterior Uveitis Treatment Market Challenges
  • 13.4 Non-infectious Anterior Uveitis Treatment Market Restraints

14 Key Findings in The Global Non-infectious Anterior Uveitis Treatment Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer